AstraZeneca launches new digital health solutions business Evinova
AstraZeneca has launched Evenova, a new digital health solutions business, within the company to expedite innovation in the life sciences industry. Evinova…
AstraZeneca has launched Evenova, a new digital health solutions business, within the company to expedite innovation in the life sciences industry. Evinova…
Bristol Myers Squibb (BMS) has received breakthrough therapy designation from the US Food and Drug Administration for its investigational therapy…
Arecor Therapeutics’ subsidiary Tetris Pharma has announced a commercialisation agreement with Goodlife for Ogluo. Under the exclusive agreement, Goodlife will…
Eden AcquisitionCo (Bidco) has signed an agreement to acquire British biopharmaceutical services company Ergomed in a deal valued at around…
Senju Pharmaceutical and Novaliq have closed a licence agreement for NOV03 (perfluorohexyloctane ophthalmic solution) to treat dry eye disease in…
The UK’s National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending the use of Pfizer’s…
ImmunoForge has expanded its licence agreement with Duke University in North Carolina, US, to jointly improve research and drug development…
KSQ Therapeutics has announced the expansion of its immuno-oncology strategic partnership with Takeda for new tumour-intrinsic targets. This partnership will…
Formosa Pharmaceuticals along with AimMax Therapeutics has submitted a new drug application (NDA) to the US Food and Drug Administration…
Boehringer Ingelheim has received breakthrough therapy designation (BTD) from the US Food and Drug Administration (FDA) for spesolimab (SPEVIGO) to…